Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinaldo Acevedo

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Methods (San Diego, Calif.)|May 5, 2009
Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responsesJudith Del Campo, Caridad Zayas, Belkis Romeu, et al.
Vaccine|July 11, 2006
Proteoliposome derived cochleate as novel adjuvantGustavo Bracho, Miriam Lastre, Judith del Campo, et al.
Vaccine|July 11, 2006
Immunological evaluation of bacterial derived Cochleate and proteoliposome as mucosal adjuvantsJudith del Campo, Miriam Lastre, Gustavo Bracho, et al.
Scandinavian Journal of Infectious Diseases|June 16, 2011
AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responsesBelkis Romeu, Elizabeth González, Caridad Zayas, et al.
Vaccine|November 11, 2008
A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c miceJosé Luis Pérez, Reinaldo Acevedo, Adriana Callicó, et al.
Plos One|October 19, 2012
Cochleates derived from Vibrio cholerae O1 proteoliposomes: the impact of structure transformation on mucosal immunisationReinaldo Acevedo, Oliver Pérez, Caridad Zayas, et al.
Vaccine|July 11, 2006
Scale up of proteoliposome derived Cochleate productionCaridad Zayas, Gustavo Bracho, Miriam Lastre, et al.
Heliyon|September 14, 2016
Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)Nya L Fraleigh, Justin Boudreau, Nitin Bhardwaj, et al.
Frontiers in Immunology|April 10, 2014
Bacterial outer membrane vesicles and vaccine applicationsReinaldo Acevedo, Sonsire Fernández, Caridad Zayas, et al.
Pharmaceutics|November 28, 2019
Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley RatsReynaldo Oliva, Nya L Fraleigh, Jordan D Lewicky, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Methods (San Diego, Calif.)|May 5, 2009
Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responsesJudith Del Campo, Caridad Zayas, Belkis Romeu, et al.
Vaccine|July 11, 2006
Proteoliposome derived cochleate as novel adjuvantGustavo Bracho, Miriam Lastre, Judith del Campo, et al.
Vaccine|July 11, 2006
Immunological evaluation of bacterial derived Cochleate and proteoliposome as mucosal adjuvantsJudith del Campo, Miriam Lastre, Gustavo Bracho, et al.
Scandinavian Journal of Infectious Diseases|June 16, 2011
AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responsesBelkis Romeu, Elizabeth González, Caridad Zayas, et al.
Vaccine|November 11, 2008
A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c miceJosé Luis Pérez, Reinaldo Acevedo, Adriana Callicó, et al.
Plos One|October 19, 2012
Cochleates derived from Vibrio cholerae O1 proteoliposomes: the impact of structure transformation on mucosal immunisationReinaldo Acevedo, Oliver Pérez, Caridad Zayas, et al.
Vaccine|July 11, 2006
Scale up of proteoliposome derived Cochleate productionCaridad Zayas, Gustavo Bracho, Miriam Lastre, et al.
Heliyon|September 14, 2016
Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1)Nya L Fraleigh, Justin Boudreau, Nitin Bhardwaj, et al.
Frontiers in Immunology|April 10, 2014
Bacterial outer membrane vesicles and vaccine applicationsReinaldo Acevedo, Sonsire Fernández, Caridad Zayas, et al.
Pharmaceutics|November 28, 2019
Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley RatsReynaldo Oliva, Nya L Fraleigh, Jordan D Lewicky, et al.
Pageof 3